Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01422980
Other study ID # NU345
Secondary ID
Status Completed
Phase N/A
First received April 21, 2011
Last updated October 7, 2016
Start date November 2010
Est. completion date July 2011

Study information

Verified date October 2016
Source Danone Research
Contact n/a
Is FDA regulated No
Health authority Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the consumption of test dairy products is effective in reducing upper gastric discomfort after 2 weeks of product consumption.


Recruitment information / eligibility

Status Completed
Enrollment 236
Est. completion date July 2011
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria:

- Male and female

- 21 - 60 years old

- Experiencing upper gastric discomfort

Exclusion Criteria:

- Participants with alarm symptoms (dysphagia, bleeding, involuntary weight loss clinically significant >10% of it habitual weight during the last 6 months).

- Participants with diagnosed severe organic esophageal medical history (endoscopic eosophagitis A, B, C or D of Los Angeles classification, peptic stenosis, Barrett oesophagus, huge hiatus hernia or para-esophageal) gastric or duodenal ulcer or high digestive haemorrhage clinical history.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
1- Test dairy product containing specific ingredients

2- Control dairy product without specific ingredients


Locations

Country Name City State
Argentina Hospital Italiano BuenosAires

Sponsors (1)

Lead Sponsor Collaborator
Danone Research

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in gastro-oesophageal symptoms as assessed by RDQ questionnaire Two timepoints are considered in the assessment of the change outcome measures: from Baseline (before product consumption) to Endpoint (i.e. final evaluation visit after 2 weeks of product consumption) No